COVIDSurg Surgical Preparedness Index (SPI) webinar

Discussion on how the new SPI tool can help reduce elective surgery cancellations this winter

Thank you to every who contributed to the Surgical Preparedness Index (SPI) study, which assessed hospitals and surgical volume for over 1600 centres in 119 countries. Congratulations to the network on the recent publication of this work in The Lancet.

We are delighted to announce our network CovidSurg webinar in our IRCAD/Medtronic series, where we will discuss how the SPI tool can now be applied to your hospital.

Join us as we dig deeper to explore:

  • Why every surgeon and anaesthetist should care about surgical preparedness?
  • How and when should I measure the SPI in my hospital?
  • How can the SPI be implemented to reduce cancellations of planned surgery?
  • Who else needs to be involved to maximise impact?
  • Which hospitals and settings could benefit the most?

This will be a unique, first global discussion of the SPI data and its impact on practice from a multidisciplinary panel - don't miss it!

The webinar will be on Monday 28th November 2022

Time: 1900 BST (UK) | 1100 Los Angeles | 1400 New York | 1500 Brasilia | 2000 CET | 2100 Riyadh

You can register for the webinar here.

 


GSU India Prioritisation Event - an overview of CEI training in Ludhiana

GSU Community Engagement and Involvement (CEI) training and consultation session at CMC Ludhiana, India

The NIHR Global Health Research Unit on Global Surgery (GSU) recently held its first international prioritisation event since the beginning of the pandemic in India, with various meetings taking place in New Delhi, Ludhiana and Kolkata.

Our first overview of the activities that took place focuses on the CEI training session and public consultation at Christian Medical College Ludhiana, India on 29th September 2022.

The training was attended by surgeons, medical students and community health workers with the aim of teaching the fundamentals of CEI and its implementation in research. CEI is a way of collaboratively working with communities who are most likely affected by research outcomes. This includes getting the perspectives of patient, carers and community leaders about the acceptability of a study and strategies to implementing and disseminating findings of completed research.

Following the training, patients and carers joined the group for a consultation on the acceptability of TIGER- a proposed trial that aims to increase access to inguinal hernia surgeries among patients in low and middle-income countries. GSU had done initial work with patients in Ghana but wanted to find out TIGER’s acceptability in the Punjab region.

CEI is an important priority of the Unit and is integrated in all stages of the research it leads. On the 27th of September, leads from GSU Hubs attended a meeting in New Delhi to discuss, among other things, future directions for CEI including a community co-developed patient survey on surgical site infections.


COVIDSurg-3 results webinar

Results from the latest dataset to be discussed this Thursday 20th October

Thank you to everyone who contributed to the CovidSurg-3 study. Outcomes data for almost 20,000 patients with perioperative SARS-CoV-2 infection has now been collected, across 937 hospitals in 89 countries.

The results have been analysed and the team responsible for the pioneering study would like to invite you to their webinar where CovidSurg-3 results will be released for the first time where they will explore:

  • Is surgery safe in the Omicron-era?
  • Does SARS-CoV-2 vaccination reduce patient risk?
  • Do patients who test positive for SARS-CoV-2 need to be delayed before surgery?
  • Can we relax COVID restrictions and increase surgical volume?

The webinar will be on Thursday 20 October 2022.
Time: 1100 Los Angeles | 1400 New York | 1500 Brasilia | 1900 BST (UK) | 2000 CET | 2100 Riyadh

You can register for the webinar here.


GSU Birmingham Team visits Rwanda Hub for SIV, Monitoring and CEI

University of Birmingham colleagues visit Rwanda for the launch of ProtectSurg and Community Engagement activities

 

Members of the Global Surgery Unit (GSU) of the University of Birmingham visited the GSU Rwanda Hub (hosted at the University of Rwanda) from 19-22 July 2022 for the ProtectSurg site initiation visit and monitoring training and Community Engagement and Involvement (CEI) training and activities. The team also spoke during the 1st University Research Open Day where they spoke about GSU’s recently-concluded trials FALCON and CHEETAH

 

ProtectSurg is a platform trial that aims to test an inhaled drug that aims to test an inhaled drug that may prevent pulmonary complications such as pneumonia and flu following surgery. FALCON, on the other hand, tested the effectiveness of alcoholic chlorhexidine versus povidone-iodine for skin preparation and the use of antibiotic-coated sutures for surgery to prevent surgical site infections (SSIs). Finally, CHEETAH aimed to look at the impact of changing gloves and instruments before wound closure in preventing SSIs.

 

The Birmingham team also visited Kibogora Hospital- one of the research spoke sites of the Rwanda Hub where training on ProtectSurg was also done. In addition, selected Community Health Workers (CHWs) in the district were invited to a CEI activity where their awareness and views on research were obtained. The CHWs were also asked about their knowledge of post-surgical care and what sort of training they would need to better support the villages they serve.

 

The visiting Birmingham team comprised Rachel Lillywhite- Trials Management Team Leader, Donna Smith- Senior Trial Manager and Michael Bahrami-Hessari- Community Engagement and Involvement Manager.